计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| M339846-10mg |
10mg |
现货 ![]() |
| |
| M339846-25mg |
25mg |
现货 ![]() |
| |
| M339846-100mg |
100mg |
现货 ![]() |
| |
| M339846-250mg |
250mg |
现货 ![]() |
| |
| M339846-1g |
1g |
现货 ![]() |
|
| 别名 | 1,4-二羟基-5,8-双[[2-[(2-羟乙基)氨基]乙基]氨基]蒽醌 | 1,4-二羟基-5,8-双[[2-[(2-羟乙基)氨基]乙基]氨基]蒽-9,10-二酮 |
|---|---|
| 英文别名 | L01DB07 | 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone | HMS2090D05 | 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione | DTXSID4046947 | Mitoxanthrone | 1,4-DIHYDROXY-5,8-BIS((2-((2-HYDROXYETHY |
| 规格或纯度 | Moligand™, ≥97% |
| 英文名称 | Mitoxantrone |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | DNA 拓扑异构酶 IIα 抑制剂 |
| 产品介绍 |
米托蒽醌是一种抑制DNA合成的DNA嵌入药物,并用作抗癌药。米托蒽醌是Topo II的抑制剂。 Mitoxantrone is a DNA intercalating drug that inhibits DNA synthesis and is used as an anti-cancer agent. Mitoxantrone is an inhibitor of Topo II. |
| 纯度 | ≥97% |
| pKa值 | pKa: 7.08 (Predicted), pKa: 9.27 (Predicted) |
|---|---|
| Ki Data | mAChR M2: Ki= 77.9 nM (human); mAChR M4: Ki= 89.8 nM (human); mAChR M1: Ki= 0.18 μM (human); SR-2C: Ki= 1.87 μM (human); HERG: Ki= 2.94 μM (human) |
| IC50 | L1210: IC₅₀= 0.04 nM (mouse); MDA-MB-435: IC₅₀= 0.35 nM (human); A2780: IC₅₀= 0.55 nM (human); HIV-1 integrase: IC₅₀= 3.8 μM; Topoisomerase II: IC₅₀= 5.3 μM |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 488179822 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione |
| INCHI | 1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2 |
| InChi Key | KKZJGLLVHKMTCM-UHFFFAOYSA-N |
| Smiles | C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO |
| Isomeric SMILES | C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO |
| 分子量 | 444.48 |
| Beilstein号 | 2795126 |
| Reaxy-Rn | 2795126 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=2795126&ln= |
| 溶解性 | 微溶于(甲醇);不溶于(水,丙酮,氯仿) |
|---|---|
| 密度 | 1.45 g/cm3 |
| 敏感性 | 对光和热敏感 |
| 折光率 | n20D1.71 |
| 沸点 | ~805.7° C at 760 mmHg (Predicted) |
| 熔点 | 170-174° C |
| 分子量 | 444.500 g/mol |
| XLogP3 | 1.000 |
| 氢键供体数Hydrogen Bond Donor Count | 8 |
| 氢键受体数Hydrogen Bond Acceptor Count | 10 |
| 可旋转键计数Rotatable Bond Count | 12 |
| 精确质量Exact Mass | 444.201 Da |
| 单同位素质量Monoisotopic Mass | 444.201 Da |
| 拓扑极表面积Topological Polar Surface Area | 163.000 Ų |
| 重原子数Heavy Atom Count | 32 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 571.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 | |
| 分析证书 | M339846 |
| 1. Zhi Li, Shuhua Han. (2022) A Chemosensor of 1,8-Dihydroxyanthraquinone PMOs Prepared in a Ternary Deep Eutectic Solvent for the Sensitive Detection of Cu2+. ACS Omega, 7 (26): (22613–22625). [PMID:35811913] [10.1021/acsomega.2c01944] |
| 2. Chunli Lou, Xiongzhen Ye, Ge Chen, Jidong Zhu, Jingwu Kang. (2021) Screening inhibitors for blocking UHRF1-methylated DNA interaction with capillary electrophoresis. JOURNAL OF CHROMATOGRAPHY A, 1636 (461790). [PMID:33340746] [10.1016/j.chroma.2020.461790] |
| 3. Tao Xiaojun, Tao Ting, Wen Yi, Yi Jiajin, He Lihua, Huang Zixuan, Nie Yu, Yao Xiaoyan, Wang Yingying, He Chunlian, Yang Xiaoping. (2018) Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency. Nanoscale Research Letters, 13 (1): (1-12). [PMID:30377872] [10.1186/s11671-018-2769-x] |
| 4. Qianyu Xu, Haoyang Fu, Jiyuan Gu, Liyu Lei, Lan Ling. (2025) Catalytic detoxification of mitoxantrone by graphitic carbon nitride (g-C3N4) supported Fe/Pd bimetallic nanoparticles. Journal of Environmental Sciences, 148 (614). [PMID:39095194] [10.1016/j.jes.2024.01.044] |
| 5. Tao Yanru, Zhao Hua, Xiang Yujie, Li Jin, Li Yanting, Hu Jiangling, Wang Hongmei, Jiang Xinhui. (2024) Development and Validation of a New High-Performance Liquid Chromatography-Ultraviolet Assay for Quantification of Mitoxantrone in Plasma of BALB/c-nu Mice. JOURNAL OF CHROMATOGRAPHIC SCIENCE, [PMID:38493310] [10.1093/chromsci/bmae007] |
| 6. Yixuan Zhao, Jiahui Zhao, Shuqin Liu, Dunqing Wang, Jian Liu, Fei Zhang, Xiangshu Chen. (2024) Melamine enhancing Cu-Fenton reaction for degradation of anthracyclines. JOURNAL OF HAZARDOUS MATERIALS, 480 (136035). [PMID:39362119] [10.1016/j.jhazmat.2024.136035] |
| 7. Haiying Liu, Yuqi Liu, Xiaoxi Lin, Jianhui Fan, Zhao Huang, Ao Li. (2024) Mitoxantrone attenuates lipopolysaccharide-induced acute lung injury via inhibition of NEDD8 activating enzyme. INTERNATIONAL IMMUNOPHARMACOLOGY, 143 (113605). [PMID:39541844] [10.1016/j.intimp.2024.113605] |
| 8. Hongjie Zhang, Rui Geng, Benyan Zheng, Jing Wang, Yuan Hu, Xiaopeng Ma. (2025) Ultrasound-Enhanced Mitochondrial Targeting for Synergistic Mitoxantrone-Based Nanotherapy in Triple-Negative Breast Cancer. ACS Applied Nano Materials, 8 (5): (2382-2392). [10.1021/acsanm.4c06594] |